{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:15:09Z","timestamp":1788200109370,"version":"build-2803163510"},"reference-count":111,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.hoc.2025.02.007","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T07:12:39Z","timestamp":1744441959000},"page":"577-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Recognizing and Managing Secondary Hemophagocytic Lymphohistiocytosis in Adults"],"prefix":"10.1016","volume":"39","author":[{"given":"Adi","family":"Zoref-Lorenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella M.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6048","key":"10.1016\/j.hoc.2025.02.007_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)61951-7","article-title":"Histiocytic medullary reticulosis","volume":"234","author":"Ronald Bodley Scott","year":"1939","journal-title":"Lancet"},{"issue":"22 Pt 3","key":"10.1016\/j.hoc.2025.02.007_bib2","first-page":"368","article-title":"[Malignant histiocytosis (histiocytic medullary reticulosis)]","author":"Takai","year":"1998","journal-title":"Ryoikibetsu Shokogun Shirizu"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/path.1700630220","article-title":"A case of histiocytic medullary reticulosis","volume":"63","author":"Mc","year":"1951","journal-title":"J Pathol Bacteriol"},{"issue":"11","key":"10.1016\/j.hoc.2025.02.007_bib4","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/1097-0142(19860601)57:11<2153::AID-CNCR2820571112>3.0.CO;2-A","article-title":"Chromosome abnormalities in familial hemophagocytic lymphohistiocytosis","volume":"57","author":"Kletzel","year":"1986","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.hoc.2025.02.007_bib5","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/1097-0142(19841201)54:11<2423::AID-CNCR2820541119>3.0.CO;2-4","article-title":"Familial hemophagocytic lymphohistiocytosis in Israel. II. Pathologic findings","volume":"54","author":"Soffer","year":"1984","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08880018909034288","article-title":"Hemophagocytic lymphohistiocytosis as a syndrome: correlation of clinicopathological data","volume":"6","author":"Nezelof","year":"1989","journal-title":"Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2025.02.007_bib7","first-page":"451","article-title":"Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases","volume":"11","author":"Stephan","year":"1993","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0022-3476(96)70408-0","article-title":"Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine","volume":"128","author":"Ravelli","year":"1996","journal-title":"J Pediatr"},{"issue":"5446","key":"10.1016\/j.hoc.2025.02.007_bib9","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.hoc.2025.02.007_bib11","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2025.02.007_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt1017-891","article-title":"Epic $12 billion deal and FDA\u2019s approval raise CAR-T to new heights","volume":"35","author":"Dolgin","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.hoc.2025.02.007_bib13","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"19","key":"10.1016\/j.hoc.2025.02.007_bib15","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/imr.13298","article-title":"Hemophagocytic lymphohistiocytosis: a disorder of T cell activation, immune regulation, and distinctive immunopathology","volume":"322","author":"Jordan","year":"2024","journal-title":"Immunol Rev"},{"issue":"15","key":"10.1016\/j.hoc.2025.02.007_bib17","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s10875-024-01797-4","article-title":"Hyperferritinemia screening to aid identification and differentiation of patients with hyperinflammatory disorders","volume":"45","author":"Carol","year":"2024","journal-title":"J Clin Immunol"},{"issue":"8","key":"10.1016\/j.hoc.2025.02.007_bib19","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1016\/S2665-9913(21)00115-6","article-title":"Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study","volume":"3","author":"Kessel","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.hoc.2025.02.007_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-031-59815-9_9","article-title":"Genetics of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"1448","author":"Grom","year":"2024","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.hoc.2025.02.007_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","article-title":"Genetic defects in cytolysis in macrophage activation syndrome","volume":"16","author":"Zhang","year":"2014","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"10.1016\/j.hoc.2025.02.007_bib22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.42099","article-title":"Identification of distinct inflammatory programs and biomarkers in systemic juvenile idiopathic arthritis and related lung disease by serum proteome analysis","volume":"74","author":"Chen","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.hoc.2025.02.007_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"issue":"S1","key":"10.1016\/j.hoc.2025.02.007_bib24","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.5045\/br.2021.2020323","article-title":"Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults","volume":"56","author":"Kim","year":"2021","journal-title":"Blood Res"},{"issue":"22","key":"10.1016\/j.hoc.2025.02.007_bib25","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood.2024026243","article-title":"HLH: diagnostics revisited and improved","volume":"144","author":"La Rosee","year":"2024","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2025.02.007_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27929","article-title":"Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: recommendations from the North American consortium for histiocytosis (NACHO)","volume":"66","author":"Jordan","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"10.1016\/j.hoc.2025.02.007_bib27","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib28","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","article-title":"Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro","volume":"135","author":"Rubin","year":"1985","journal-title":"J Immunol"},{"issue":"26","key":"10.1016\/j.hoc.2025.02.007_bib29","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/bloodadvances.2017012310","article-title":"Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH","volume":"1","author":"Hayden","year":"2017","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/bloodadvances.2022007953","article-title":"sCD25 as an independent adverse prognostic factor in adult patients with HLH: results of a multicenter retrospective study","volume":"7","author":"Wimmer","year":"2023","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s10875-020-00950-z","article-title":"Biomarkers for early diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients","volume":"41","author":"Debaugnies","year":"2021","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-82760-6","article-title":"The role of C-reactive protein and ferritin in the diagnosis of HLH, adult-onset still\u2019s disease, and COVID-19 cytokine storm","volume":"14","author":"Goubran","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib34","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ejh.14267","article-title":"CRP and sCD25 help distinguish between adult-onset Still\u2019s disease and HLH","volume":"113","author":"Beckett","year":"2024","journal-title":"Eur J Haematol"},{"issue":"9","key":"10.1016\/j.hoc.2025.02.007_bib35","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.hoc.2025.02.007_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis","volume":"139","author":"Zoref-Lorenz","year":"2022","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.hoc.2025.02.007_bib37","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Shakoory","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"9927","key":"10.1016\/j.hoc.2025.02.007_bib38","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2025.02.007_bib39","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3389\/fimmu.2017.01902","article-title":"Epstein-barr virus and hemophagocytic lymphohistiocytosis","volume":"8","author":"Marsh","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.hoc.2025.02.007_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-3-031-59815-9_16","article-title":"Cytokine storm syndromes associated with epstein-barr virus","volume":"1448","author":"Verbist","year":"2024","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/hematology.2023000463","article-title":"Inflamed-HLH, MAS, or something else?","volume":"2023","author":"Kumar","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"11","key":"10.1016\/j.hoc.2025.02.007_bib42","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1182\/blood.2019003886","article-title":"Nivolumab treatment of relapsed\/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults","volume":"135","author":"Liu","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1186\/s12879-024-10145-1","article-title":"GATA2 deficiency and hemophagocytic lymphohistiocytosis (HLH): a systematic review of reported cases","volume":"24","author":"Rukerd","year":"2024","journal-title":"BMC Infect Dis"},{"issue":"14","key":"10.1016\/j.hoc.2025.02.007_bib44","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood.2024024144","article-title":"Inflammasome activation in patients with Kaposi sarcoma herpesvirus-associated diseases","volume":"144","author":"Lage","year":"2024","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/idr16020012","article-title":"Hemophagocytic lymphohistiocytosis (HLH) in patients with tick-borne illness: a scoping review of 98 cases","volume":"16","author":"Jevtic","year":"2024","journal-title":"Infect Dis Rep"},{"issue":"7","key":"10.1016\/j.hoc.2025.02.007_bib46","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1473-3099(06)70524-2","article-title":"Tuberculosis-associated haemophagocytic syndrome","volume":"6","author":"Brastianos","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib47","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofv055","article-title":"Histoplasmosis-Induced hemophagocytic syndrome: a case series and review of the literature","volume":"2","author":"Townsend","year":"2015","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12879-017-2732-y","article-title":"Acute HIV infection presenting as hemophagocytic lymphohistiocytosis: case report and review of the literature","volume":"17","author":"Manji","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.hoc.2025.02.007_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009417","article-title":"Differential recognition of HIV-stimulated IL-1beta and IL-18 secretion through NLR and NAIP signalling in monocyte-derived macrophages","volume":"17","author":"Triantafilou","year":"2021","journal-title":"PLoS Pathog"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib50","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1093\/cid\/ciac717","article-title":"Severe mycobacterial immune reconstitution inflammatory syndrome (IRIS) in advanced human immunodeficiency virus (HIV) has features of hemophagocytic lymphohistiocytosis and requires prolonged immune suppression","volume":"76","author":"Rocco","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib51","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/cid\/ciac514","article-title":"Polyfunctional antigen specific CD4+ T cell responses in patients with human immunodeficiency virus\/AIDS and histoplasmosis immune reconstitution inflammatory syndrome","volume":"76","author":"Manion","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.hoc.2025.02.007_bib52","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/cid\/ciz499","article-title":"Dengue infection complicated by hemophagocytic lymphohistiocytosis: experiences from 180 patients with severe dengue","volume":"70","author":"Kan","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib53","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1182\/blood-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn","year":"2018","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaip.2020.11.041","article-title":"Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease-single-center experience from North India","volume":"9","author":"Vignesh","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib55","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.hoc.2025.02.007_bib56","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/978-3-031-59815-9_29","article-title":"Hemophagocytic lymphohistiocytosis in the context of hematological malignancies and solid tumors","volume":"1448","author":"Zoref-Lorenz","year":"2024","journal-title":"Adv Exp Med Biol"},{"issue":"17","key":"10.1016\/j.hoc.2025.02.007_bib57","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12185-019-02623-z","article-title":"Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series","volume":"109","author":"Pasvolsky","year":"2019","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib59","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","article-title":"A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome","volume":"93","author":"Tsuji","year":"2014","journal-title":"Ann Hematol"},{"issue":"6","key":"10.1016\/j.hoc.2025.02.007_bib60","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s11606-022-07395-7","article-title":"A case of chronic lymphocytic leukemia complicated by hemophagocytic lymphohistiocytosis: identifying the aberrant immune response","volume":"37","author":"Zoref-Lorenz","year":"2022","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.hoc.2025.02.007_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27400","article-title":"Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis","volume":"65","author":"Gurunathan","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.hoc.2025.02.007_bib62","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.hoc.2025.02.007_bib63","first-page":"1","article-title":"Malignancy-associated HLH: mechanisms, diagnosis, and treatment of a severe hyperinflammatory syndrome","author":"Zoref-Lorenz","year":"2024","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood.2023020715","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival","volume":"143","author":"Lofstedt","year":"2024","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.hoc.2025.02.007_bib65","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Rosee","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/hematology.2023000509","article-title":"Inpatient recognition and management of HLH","volume":"2023","author":"Zoref-Lorenz","year":"2023","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib67","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.3324\/haematol.2019.220301","article-title":"Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial","volume":"105","author":"Liang","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3324\/haematol.2013.097394","article-title":"Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy","volume":"99","author":"Delavigne","year":"2014","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.hoc.2025.02.007_bib69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.hoc.2025.02.007_bib70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fimmu.2020.00524","volume":"11","author":"Sandler","year":"2020","journal-title":"Front Immunol"},{"issue":"21","key":"10.1016\/j.hoc.2025.02.007_bib71","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/blood-2017-06-793141","article-title":"Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy","volume":"130","author":"Hay","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2025.02.007_bib72","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jtct.2023.04.001","article-title":"Anakinra for refractory cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T cell therapy","volume":"29","author":"Gazeau","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib73","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"3\u20134","key":"10.1016\/j.hoc.2025.02.007_bib74","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-024-01013-w","article-title":"Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy","volume":"46","author":"Hughes","year":"2024","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.hoc.2025.02.007_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2023.03.006","article-title":"Immune effector cell associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS)","author":"Hines","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib76","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s12276-024-01182-6","article-title":"Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis\/macrophage activation syndrome: a translational perspective","volume":"56","author":"Nguyen","year":"2024","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hoc.2025.02.007_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102143","article-title":"Epidemiology, characteristics, and outcomes of adult haemophagocytic lymphohistiocytosis in the USA, 2006-19: a national, retrospective cohort study","volume":"62","author":"Abdelhay","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.hoc.2025.02.007_bib79","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/mr\/roac133","article-title":"Incidence of opportunistic infections in patients with rheumatoid arthritis treated with different molecular-targeted drugs: a population-based retrospective cohort study","volume":"33","author":"Takabayashi","year":"2023","journal-title":"Mod Rheumatol"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib80","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-024-03434-2","article-title":"Clinical practice pattern of Pneumocystis pneumonia prophylaxis in systemic lupus erythematosus: a cross-sectional study from lupus registry of nationwide institutions (LUNA)","volume":"26","author":"Onishi","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.hoc.2025.02.007_bib81","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241245517","article-title":"Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study","volume":"15","author":"Lee","year":"2024","journal-title":"Ther Adv Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2025.02.007_bib82","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ejh.14029","article-title":"Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis\/macrophage activation syndrome: a systematic review","volume":"111","author":"Charlesworth","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.hoc.2025.02.007_bib83","article-title":"Long-term efficacy of MAS825, a bispecific anti-IL1beta and IL-18 monoclonal antibody, in two patients with sJIA and recurrent episodes of MAS","author":"Caorsi","year":"2024","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.hoc.2025.02.007_bib84","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1093\/rheumatology\/kead612","article-title":"Experience of anti-IL-1beta and anti-IL-18 combined therapy (MAS825) in recurrent and recalcitrant macrophage activation syndrome","volume":"63","author":"Caglayan","year":"2024","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.hoc.2025.02.007_bib85","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1093\/rheumatology\/keab202","article-title":"Severe hepatotoxicity as a rare side effect of anakinra in a patient with systemic JIA","volume":"60","author":"Murray","year":"2021","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.hoc.2025.02.007_bib86","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/ard-2024-225851","article-title":"EULAR\/PReS recommendations for the diagnosis and management of Still\u2019s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still\u2019s disease","volume":"83","author":"Fautrel","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib87","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12969-022-00735-1","article-title":"TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases","volume":"20","author":"Aslani","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"issue":"7","key":"10.1016\/j.hoc.2025.02.007_bib88","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10875-023-01521-8","article-title":"Clinical symptoms, laboratory parameters and long-term follow-up in a national DADA2 cohort","volume":"43","author":"Andriessen","year":"2023","journal-title":"J Clin Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib89","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaci.2022.01.024","article-title":"Mutations at the C-terminus of CDC42 cause distinct hematopoietic and autoinflammatory disorders","volume":"150","author":"Coppola","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib90","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/mrcr\/rxab026","article-title":"Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report","volume":"6","author":"Cerme","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"issue":"8","key":"10.1016\/j.hoc.2025.02.007_bib91","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/annrheumdis-2021-221708","article-title":"Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease","volume":"81","author":"Wang","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.hoc.2025.02.007_bib92","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.41999","article-title":"First description of late-onset autoinflammatory disease due to somatic NLRC4 mosaicism","volume":"74","author":"Ionescu","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib93","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.39960","article-title":"Identification of a high-frequency somatic NLRC4 mutation as a cause of autoinflammation by pluripotent cell-based phenotype dissection","volume":"69","author":"Kawasaki","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib94","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/bloodadvances.2019001272","article-title":"Identification of germline variants in adults with hemophagocytic lymphohistiocytosis","volume":"4","author":"Miller","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib95","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jaci.2023.07.023","article-title":"Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants","volume":"153","author":"Bloch","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"26","key":"10.1016\/j.hoc.2025.02.007_bib96","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood.2020008206","article-title":"Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis","volume":"136","author":"Miller","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2025.02.007_bib97","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/bloodadvances.2023011733","article-title":"Somatic mutations in FAS pathway increase hemophagocytic lymphohistiocytosis risk in patients with T- and\/or NK-cell lymphoma","volume":"8","author":"Liu","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib98","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/mrcr\/rxad041","article-title":"Long-term remission of VEXAS syndrome achieved by a single course of CHOP therapy: a case report","volume":"8","author":"Miyoshi","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"issue":"1","key":"10.1016\/j.hoc.2025.02.007_bib99","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40164-021-00229-y","article-title":"Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis","volume":"10","author":"Ren","year":"2021","journal-title":"Exp Hematol Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2025.02.007_bib100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s12185-022-03430-9","article-title":"Anakinra for the treatment of adult secondary HLH: a retrospective experience","volume":"116","author":"Naymagon","year":"2022","journal-title":"Int J Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib101","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/bjh.15988","article-title":"Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis","volume":"186","author":"Song","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2025.02.007_bib102","article-title":"Low-dose emapalumab combined with chemotherapy for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","author":"Zhu","year":"2024","journal-title":"Transpl Immunol"},{"issue":"9","key":"10.1016\/j.hoc.2025.02.007_bib103","first-page":"2998","article-title":"Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis","volume":"109","author":"Johnson","year":"2024","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.hoc.2025.02.007_bib104","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000001046","article-title":"Ruxolitinib, IV immunoglobulin, and high-dose glucocorticoids for critically ill adults with secondary hemophagocytic lymphohistiocytosis: a single-center observational pilot study","volume":"6","author":"Scholz","year":"2024","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.hoc.2025.02.007_bib105","article-title":"Ruxolitinib-based regimen in children with autoimmune disease or autoinflammatory disease-related haemophagocytic lymphohistiocytosis","author":"Fang","year":"2024","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib106","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ejh.13593","article-title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series","volume":"106","author":"Hansen","year":"2021","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib107","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2015.06.011","article-title":"The role of hematopoietic stem cell transplantation in treatment of hemophagocytic lymphohistiocytosis","volume":"29","author":"Nikiforow","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.hoc.2025.02.007_bib108","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/s41409-022-01668-9","article-title":"Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature","volume":"57","author":"Masood","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1016\/j.hoc.2025.02.007_bib109","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/bloodadvances.2022007012","article-title":"Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis","volume":"7","author":"Gooptu","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.hoc.2025.02.007_bib110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41409-022-01634-5","article-title":"Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT","volume":"57","author":"Machowicz","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"20","key":"10.1016\/j.hoc.2025.02.007_bib111","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1182\/blood.2023023287","article-title":"Transplantation in adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: yes or no?","volume":"144","author":"Yao","year":"2024","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858825000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858825000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T14:41:43Z","timestamp":1747924903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858825000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":111,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0889858825000255"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2025.02.007","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognizing and Managing Secondary Hemophagocytic Lymphohistiocytosis in Adults","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2025.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}